In a recently published prospective study comparing photon-counting detector computed tomography (PCD CT) versus energy-integrating detector CT (EID CT) in patients with persistent symptoms after COVID-19 infection, researchers found that PCD CT discovered additional lung abnormalities in half of the study participants.
For enhanced image quality and detection of subtle lung abnormalities in people who have had COVID-19 infection, emerging research suggests that photon-counting detector computed tomography (PCD CT) may be superior to conventional CT.
For the prospective study, recently published in Radiology, researchers at a tertiary care university hospital utilized both PCD CT and energy-integrating detector CT (EID CT) in same day assessment of 20 patients (mean age of 54) who presented with a past history of COVID-19, a median involvement of 10 percent of lung volume, 3.5 lobes and persistent symptoms including cough, fatigue, or dyspnea.
While linear bands and ground-glass opacities were the most common findings with EID CT, the researchers said PCD CT uncovered additional lung abnormalities in half of the study cohort. These findings included bronciolectasis (10 of 20 participants) and reticulations (seven of 20 participants), according to the study. The study authors added that PCD CT showed fine reticulations for six participants in areas that had been identified as ground glass opacities by EID CT.
“Photon-counting detector (PCD) CT revealed subtle lung abnormalities in symptomatic participants with persistent COVID-19 symptoms that were not detectable on energy-integrating detector (EID) CT but may be indicative of irreversible fibrosis,” wrote Benedikt H. Heidinger, M.D., who is affiliated with the Department of Biomedical Imaging and Image-Guided Therapy at the Medical University of Vienna in Austria, and colleagues.
(Editor’s note: For related articles, see “Study Says AI Can Enhance Chest CT Assessment of Bronchiectasis in Ever-Smokers” and “Chest CT Study Shows Benefits of COVID-19 Vaccines in Reducing Incidence and Severity of Related Pneumonia.”)
In regard to image quality, the researchers said the reviewing radiologists found that 0.4 mm section thickness for PCD CT images was “definitely better” than 1.0 mm for all of the participants of the study. Heidinger and colleagues noted that 0.4 mm PCD CT found 17 abnormalities in nine patients in comparison to 1.0 mm PCD CT. Yet the use of 1.0 mm PCD CT in comparison to 1.0 mm EID CT revealed five abnormalities in four participants. While noting a significantly higher signal-to-noise (SNR) ratio for 1.0 mm sections of PCD CT in comparison to EID CT, the researchers said the SNR ratio was reduced for 0.2 mm and 0.4 mm sections.
“Our findings suggest that 0.4 mm sections represent a favorable compromise between ultra-high resolution and perceived (and quantitative) image quality, permitting confident detection of subtle lung abnormalities,” added Heidinger and colleagues.
Beyond the small sample size, the study authors said other possible limitations may have included slight variation between EID CT and PCD CT in the use of sharp edge-enhancing CT reconstruction kernels to help detect subtle abnormalities. They acknowledged that false positive findings on PCD CT could not be ruled out due to a lack of histopathological correlation with the study findings. The researchers added that sequential assessment of EID CT and PCD CT images may have contributed to biased views of image quality and may have prevented detection of abnormalities that were only visible on EID CT.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.
Five-Year Study Shows Significant Overuse of CT Angiography in the ER
April 2nd 2024Researchers noted a 67.4 percent increase in head and neck CT angiography and a 38 percent reduction in findings of acute pathology in a recent comparison of 2017 and 2021 statistics for headache and/or dizziness presentations at the emergency department of an urban academic medical center.
Interventional Radiology Study Shows Low Breast Cancer Recurrence 16 Months After Cryoablation
March 29th 2024In a cohort of patients with invasive breast cancer and tumor sizes ranging between 0.3 to 9 cm, image-guided cryoablation was associated with a 10 percent recurrence rate at 16 months, according to research recently presented at the Society of Interventional Radiology (SIR) conference.